VERA 10-Q: SEC filing
Vera Therapeutics
Filed with the SEC on · accession 0001193125-26-449826
VERA filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -5.7% by the first close after the filing.
Summary of the filing
Vera Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, confirming its status as a large accelerated filer with 72,298,770 shares of Class A common stock outstanding.
Key details
How VERA stock reacted
Close before
$31.97
Nov 4, 2026
First close after
-5.72%
$30.14
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VERA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VERA?
Click hereFrequently asked questions
What did VERA file with the SEC on Nov 5, 2026?
VERA filed a 10-Q (SEC filing). Vera Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, confirming its status as a large accelerated filer with 72,298,770 shares of Class A common stock outstanding.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did VERA stock react to this filing?
VERA closed at $31.97 before the filing and $30.14 on Nov 5, 2026 (-5.72%).
Other VERA SEC filings
Get alerts when VERA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days